tetano
Editor, Senior Moderator
Microbes Infect. 2017 Aug 30. pii: S1286-4579(17)30119-3. doi: 10.1016/j.micinf.2017.08.004. [Epub ahead of print]
[h=1]Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.[/h] Liu L[SUP]1[/SUP], Lu J[SUP]1[/SUP], Zhou J[SUP]1[/SUP], Li Z[SUP]1[/SUP], Zhang H[SUP]1[/SUP], Wang D[SUP]2[/SUP], Shu Y[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Human infections with Eurasian avian-like swine influenza H1N1 viruses have been reported in China in past years. One case resulted in death and others were mild case. In 2016, the World Health Organization recommended the use of A/Hunan/42443/2015(H1N1) virus to construct the first candidate vaccine strain for Eurasian avian-like swine influenza H1N1 viruses. Previous reports showed that the neuraminidase of A/Puerto Rico/8/34(H1N1) might improve the viral yield of reassortant viruses. Therefore, we constructed two reassortant candidate vaccine viruses of A/Hunan/42443/2015(H1N1) by reverse genetic technology, with (6+2) and (7+1) gene constitution, respectively. The (6+2) virus had hemagglutinin and neuraminidase from A/Hunan/42443/2015, and the (7+1) one had hemagglutinin from A/Hunan/42443/2015, while all the other genes were from A/Puerto Rico/8/34. Our data revealed that although the neuraminidase of the (7+1) virus was from high yield A/Puerto Rico/8/34, the hemagglutination titer and the hemagglutinin protein content of the (7+1) virus was not higher than that of the (6+2) virus. Both of the (7+1) and (6+2) viruses reached a similar level to that of A/Puerto Rico/8/34 at the usual harvest time in vitro. Therefore, both reassortant viruses are potential candidate vaccine viruses, which could contribute to pandemic preparedness.
Copyright ? 2017. Published by Elsevier Masson SAS.
[h=4]KEYWORDS:[/h] A (H1N1); Eurasian avian-like influenza; Influenza virus; Reverse genetic; Vaccine
PMID: 28859895 DOI: 10.1016/j.micinf.2017.08.004
[h=1]Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.[/h] Liu L[SUP]1[/SUP], Lu J[SUP]1[/SUP], Zhou J[SUP]1[/SUP], Li Z[SUP]1[/SUP], Zhang H[SUP]1[/SUP], Wang D[SUP]2[/SUP], Shu Y[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Human infections with Eurasian avian-like swine influenza H1N1 viruses have been reported in China in past years. One case resulted in death and others were mild case. In 2016, the World Health Organization recommended the use of A/Hunan/42443/2015(H1N1) virus to construct the first candidate vaccine strain for Eurasian avian-like swine influenza H1N1 viruses. Previous reports showed that the neuraminidase of A/Puerto Rico/8/34(H1N1) might improve the viral yield of reassortant viruses. Therefore, we constructed two reassortant candidate vaccine viruses of A/Hunan/42443/2015(H1N1) by reverse genetic technology, with (6+2) and (7+1) gene constitution, respectively. The (6+2) virus had hemagglutinin and neuraminidase from A/Hunan/42443/2015, and the (7+1) one had hemagglutinin from A/Hunan/42443/2015, while all the other genes were from A/Puerto Rico/8/34. Our data revealed that although the neuraminidase of the (7+1) virus was from high yield A/Puerto Rico/8/34, the hemagglutination titer and the hemagglutinin protein content of the (7+1) virus was not higher than that of the (6+2) virus. Both of the (7+1) and (6+2) viruses reached a similar level to that of A/Puerto Rico/8/34 at the usual harvest time in vitro. Therefore, both reassortant viruses are potential candidate vaccine viruses, which could contribute to pandemic preparedness.
Copyright ? 2017. Published by Elsevier Masson SAS.
[h=4]KEYWORDS:[/h] A (H1N1); Eurasian avian-like influenza; Influenza virus; Reverse genetic; Vaccine
PMID: 28859895 DOI: 10.1016/j.micinf.2017.08.004